UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence

The Journal of infectious diseases, 2020-03, Vol.221 (Supplement_1), p.S23-S31

2020

Volltextzugriff (PDF)

Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines

The Journal of infectious diseases, 2020-03, Vol.221 (Supplement_1), p.S103-S108

2020

Volltextzugriff (PDF)

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

Clinical infectious diseases, 2008-03, Vol.46 (6), p.840-846

2008

Volltextzugriff (PDF)

Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients

Clinical infectious diseases, 2014-12, Vol.59 (11), p.1537-1545

2014

Volltextzugriff (PDF)

Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis

Clinical infectious diseases, 2021-07, Vol.73 (1), p.101-106

2021

Volltextzugriff (PDF)

Choice of Study Populations for Vaccines

The Journal of infectious diseases, 2020-03, Vol.221 (Supplement_1), p.S128-S134

2020

Volltextzugriff (PDF)

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

Journal of antimicrobial chemotherapy, 2010-12, Vol.65 (12), p.2628-2640

2010

Volltextzugriff (PDF)

Evaluation of Cytomegalovirus (CMV)-Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV-Specific T Cell Reconstitution in Kidney Transplant Recipients

The Journal of infectious diseases, 2010-08, Vol.202 (4), p.585-594

2010

Volltextzugriff (PDF)

Clinical Aspects of Cytomegalovirus Antiviral Resistance in Solid Organ Transplant Recipients

Clinical infectious diseases, 2013-04, Vol.56 (7), p.1018-1029

2013

Volltextzugriff (PDF)

Cytomegalovirus Humoral Response Against Epithelial Cell Entry-Mediated Infection in the Primary Infection Setting After Hematopoietic Cell Transplantation

The Journal of infectious diseases, 2020-04, Vol.221 (9), p.1470-1479

2020

Volltextzugriff (PDF)

Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients

Journal of the Pediatric Infectious Diseases Society, 2024-02, Vol.13 (Supplement_1), p.S14-S21

2024

Volltextzugriff (PDF)

Impact of Current Transplantation Management on the Development of Cytomegalovirus Disease after Renal Transplantation

Clinical infectious diseases, 2008-10, Vol.47 (7), p.875-882

2008

Volltextzugriff (PDF)

Preventing Post-Organ Transplantation Cytomegalovirus Disease with Ganciclovir: A Meta-Analysis Comparing Prophylactic and Preemptive Therapies

Clinical infectious diseases, 2006-10, Vol.43 (7), p.869-880

2006

Volltextzugriff (PDF)

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

Clinical infectious diseases, 2001-07, Vol.33 (2), p.139-144

Dykewicz, Clare A.

2001

Volltextzugriff (PDF)

Ganciclovir/Valganciclovir Prophylaxis Decreases Cytomegalovirus-Related Events and Bronchiolitis Obliterans Syndrome after Lung Transplantation

Clinical infectious diseases, 2008-03, Vol.46 (6), p.831-839

2008

Volltextzugriff (PDF)

Incidence and Clinical Features of Ganciclovir- Resistant Cytomegalovirus Disease in Heart Transplant Recipients

Clinical infectious diseases, 2007-08, Vol.45 (4), p.439-447

2007

Volltextzugriff (PDF)

Cytomegalovirus-Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell Transplantation

Clinical infectious diseases, 2009-12, Vol.49 (12), p.1851-1860

2009

Volltextzugriff (PDF)

Improving Outcomes for Solid-Organ Transplant Recipients At Risk from Cytomegalovirus Infection: Late-Onset Disease and Indirect Consequences

Clinical infectious diseases, 2008-03, Vol.46 (5), p.732-740

2008

Volltextzugriff (PDF)

Effectiveness of Valganciclovir 900 mg versus 450 mg for Cytomegalovirus Prophylaxis in Transplantation: Direct and Indirect Treatment Comparison Meta-analysis

Clinical infectious diseases, 2011-02, Vol.52 (3), p.313-321

2011

Volltextzugriff (PDF)

Absence of Cytomegalovirus-Resistance Mutations after Valganciclovir Prophylaxis, in a Prospective Multicenter Study of Solid-Organ Transplant Recipients

The Journal of infectious diseases, 2004-05, Vol.189 (9), p.1615-1618

2004

Volltextzugriff (PDF)

Longitudinal Assessment of Cytomegalovirus (CMV)—Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV Disease

The Journal of infectious diseases, 2007-03, Vol.195 (5), p.633-644

2007

Volltextzugriff (PDF)

Cytomegalovirus and polyomavirus BK posttransplant

Nephrology, dialysis, transplantation, 2007-09, Vol.22 (suppl-8), p.viii72-viii82

2007

Volltextzugriff (PDF)

Valganciclovir as Treatment for Cytomegalovirus Disease in Solid Organ Transplant Recipients

Clinical infectious diseases, 2008-01, Vol.46 (1), p.20-27

2008

Volltextzugriff (PDF)

High Incidence of Ganciclovir-Resistant Cytomegalovirus Infection among Lung Transplant Recipients Receiving Preemptive Therapy

The Journal of infectious diseases, 2002-01, Vol.185 (1), p.20-27

2002

Volltextzugriff (PDF)

Allograft Rejection Predicts the Occurrence of Late-Onset Cytomegalovirus (CMV) Disease among CMV-Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral Ganciclovir

The Journal of infectious diseases, 2001-12, Vol.184 (11), p.1461-1464

2001

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation Proceedings

KollektionOxford Journals

ThemaTransplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)

Erscheinungsjahr

n.n

Thema

Humans
(100)
Life Sciences & Biomedicine
(97)
Science & Technology
(97)
Cytomegalovirus Infections - Prevention & Control
(88)
Cytomegalovirus
(81)
Infectious Diseases
(74)
Biological And Medical Sciences
(68)
Microbiology
(68)
Medical Sciences
(66)
Immunology
(65)
Infections
(53)
Adult
(50)
Cytomegalovirus Infections
(47)
Antiviral Agents - Therapeutic Use
(45)
Female
(44)
Male
(43)
Middle Aged
(42)
Preventive Medicine
(40)
Ganciclovir - Therapeutic Use
(37)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford University Press Journals Current
(101)
MEDLINE
(101)
Oxford Journals 2020 Medicine
(101)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(101)
EZB Electronic Journals Library
(95)
Publisher
(74)
JSTOR Complete Journals
(68)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence

Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients

Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis

Choice of Study Populations for Vaccines

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

Evaluation of Cytomegalovirus (CMV)-Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV-Specific T Cell Reconstitution in Kidney Transplant Recipients

Clinical Aspects of Cytomegalovirus Antiviral Resistance in Solid Organ Transplant Recipients

Cytomegalovirus Humoral Response Against Epithelial Cell Entry-Mediated Infection in the Primary Infection Setting After Hematopoietic Cell Transplantation

Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients

Impact of Current Transplantation Management on the Development of Cytomegalovirus Disease after Renal Transplantation

Preventing Post-Organ Transplantation Cytomegalovirus Disease with Ganciclovir: A Meta-Analysis Comparing Prophylactic and Preemptive Therapies

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

Ganciclovir/Valganciclovir Prophylaxis Decreases Cytomegalovirus-Related Events and Bronchiolitis Obliterans Syndrome after Lung Transplantation

Incidence and Clinical Features of Ganciclovir- Resistant Cytomegalovirus Disease in Heart Transplant Recipients

Cytomegalovirus-Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell Transplantation

Improving Outcomes for Solid-Organ Transplant Recipients At Risk from Cytomegalovirus Infection: Late-Onset Disease and Indirect Consequences

Effectiveness of Valganciclovir 900 mg versus 450 mg for Cytomegalovirus Prophylaxis in Transplantation: Direct and Indirect Treatment Comparison Meta-analysis

Absence of Cytomegalovirus-Resistance Mutations after Valganciclovir Prophylaxis, in a Prospective Multicenter Study of Solid-Organ Transplant Recipients

Longitudinal Assessment of Cytomegalovirus (CMV)—Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV Disease

Cytomegalovirus and polyomavirus BK posttransplant

Valganciclovir as Treatment for Cytomegalovirus Disease in Solid Organ Transplant Recipients

High Incidence of Ganciclovir-Resistant Cytomegalovirus Infection among Lung Transplant Recipients Receiving Preemptive Therapy

Allograft Rejection Predicts the Occurrence of Late-Onset Cytomegalovirus (CMV) Disease among CMV-Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral Ganciclovir

Aktive Filter

Suchergebnisse filtern